Share the post "Epigral : Q1 2024 Financial Quarterly Report : YoY Sales Up 43.15 %, QoQ Up 24.12 %"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 43.15 % in the past year, substantial increase in net sales/revenue by 24.12 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 77.25 %. Marginal increase in other income during this quarter, up by 12.52%.
- Profit over the Year and quarter: Significant improvement in profitability for Epigral Limited. Notable increase of 172.54 % in net profit Year to Year, Epigral Limited’s profitability increased by 11.12 % in this quarter.
- EPS over the Year and quarter: EPS increased by 172.69 % Year to Year. EPS increased by 11.13 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 454.892 Cr | Rs. 524.633 Cr | Rs. 651.2 Cr | + 24.12 % | + 43.15 % |
Expenses | Rs. 359.7 Cr | Rs. 369.24 Cr | Rs. 474.8 Cr | + 28.59 % | + 32 % |
Operating Profit | Rs. 95.19 Cr | Rs. 155.39 Cr | Rs. 176.4 Cr | + 13.52 % | + 85.31 % |
OPM % | 20.93 % | 29.62 % | 27.09 % | -2.53 % | + 6.16 % |
Other Income | Rs. 1.354 Cr | Rs. 2.133 Cr | Rs. 2.4 Cr | + 12.52 % | + 77.25 % |
Interest | Rs. 18.34 Cr | Rs. 13.69 Cr | Rs. 14.25 Cr | + 4.09 % | -22.3 % |
Depreciation | Rs. 30.8 Cr | Rs. 30.38 Cr | Rs. 33.45 Cr | + 10.11 % | + 8.6 % |
Profit before tax | Rs. 47.4 Cr | Rs. 113.45 Cr | Rs. 131.1 Cr | + 15.56 % | + 176.58 % |
Tax % | 33.42 % | 32.06 % | 34.39 % | + 2.33 % | + 0.97 % |
Net Profit | Rs. 31.51 Cr | Rs. 77.28 Cr | Rs. 85.87 Cr | + 11.12 % | + 172.52 % |
EPS in Rs | Rs. 7.58 | Rs. 18.6 | Rs. 20.67 | + 11.13 % | + 172.69 % |
Today, we’re looking at Epigral Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 43.15 %. However, it did see a marginal increase of 24.12 % from the previous quarter. Expenses ticked up slightly by 28.59 % quarter-on-quarter, aligning with the annual rise of 32 %. Operating profit, while up 85.31 % compared to last year, faced a quarter-on-quarter increase of 13.52 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 6.16 %, but a shrinkage of -2.53 % sequentially. Other income rose by 12.52 % compared to the last quarter, despite an annual growth of 77.25 %. Interest expenses surged remarkably by 4.09 % from the previous quarter, yet the year-over-year decrease remains at a moderate -22.3 %. Depreciation costs climbed by 10.11 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 8.6 %. Profit before tax grew annually by 176.58 % but saw an increase from the preceding quarter by 15.56 %.
Tax expenses as a percentage of profits increased slightly by 0.97 % compared to last year, with a more notable quarter-on-quarter increase of 2.33 %. Net profit rose by 172.52 % year-on-year but experienced a 11.12 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 172.69 % but a quarterly rise of 11.13 %. In summary, Epigral Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 454.892 Cr | Rs. 524.633 Cr | Rs. 651.2 Cr | + 24.12 % | + 43.15 % |
Expenses | Rs. 359.7 Cr | Rs. 369.24 Cr | Rs. 474.8 Cr | + 28.59 % | + 32 % |
Operating Profit | Rs. 95.19 Cr | Rs. 155.39 Cr | Rs. 176.4 Cr | + 13.52 % | + 85.31 % |
Net Profit | Rs. 31.51 Cr | Rs. 77.28 Cr | Rs. 85.87 Cr | + 11.12 % | + 172.52 % |
EPS in Rs | Rs. 7.58 | Rs. 18.6 | Rs. 20.67 | + 11.13 % | + 172.69 % |
In reviewing Epigral Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 43.15 % year-on-year growth, however, there was a minor increase of 24.12 % from the previous quarter. Expenses rose by 32 % compared to the previous year, with a 28.59 % increase quarter-on-quarter. Operating Profit surged by 85.31 % annually, and saw a 13.52 % increase from the last quarter.
Net Profit showed yearly increase of 172.52 %, and experienced a 11.12 % increase from the previous quarter. Earnings Per Share (EPS) rose by 172.69 % annually, however rose by 11.13 % compared to the last quarter. In essence, while Epigral Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.